More than Body Appearance! Improving body image in young women through a functionality‐focused intervention combined with psychoeducation: A randomized controlled trial
Abstract
Abstract Objectives Body dissatisfaction is a public health concern, prevalent among women. This study aims to investigate the efficacy of a 2‐week online functionality‐focused intervention combined with psychoeducation on improving body image among young women at both high and low risk of Body Image Disorders (BIDs). Design A randomized controlled trial was conducted among young women at high risk and low risk of developing BIDs. Methods In total, 231 young women (n = 64 at high risk of BIDs) were randomized into: experimental (n = 113) and waitlist (n = 118) groups. The experimental group underwent the intervention at baseline (T0) for 15 days (T1), while the waitlist group started the intervention at T1 for 15 days (T2). Participants completed questionnaires about body and functionality appreciation, eating disorders (EDs) risk and extreme body dissatisfaction at baseline, 15 days from baseline and 30 days from baseline. Results Mixed linear models revealed enhancements in body and functionality appreciation post‐intervention for women at both high risk and low risk of BIDs. Reductions in EDs risk and body dissatisfaction were observed in participants at high risk. Conclusions The intervention proves to be useful in promoting a positive body image (i.e. body and functionality appreciation) in women at both high and low risk of BIDs, while the results concerning the risk of developing EDs and extreme body dissatisfaction are more nuanced.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 231 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.